Morning Stock Tips, Nov. 14, 2026: AMAT, CSCO, BN, FTS and FNV on the Weekend Research List
This weekend research edition looks at five names after Friday's close: Applied Materials (AMAT), Cisco Systems (CSCO), Brookfield Corporation (BN), Fortis (FTS.TO) and Franco-Nevada (FNV). U.S. and Canadian equity markets are closed this weekend. The prices below are Friday closing prices, not executable weekend quotes.
Market snapshot (Friday, Nov. 13 close)
S&P 500 -0.4% to 7,561.67; Nasdaq -0.9% to 25,136.27; Dow +0.1% to 52,347.55. The S&P 500 still gained 2.5% for the week. AI shares sold off amid Nvidia leadership uncertainty and hotter inflation/rate concerns. US and Canadian equity markets are closed today. All stock prices below are Friday closing prices, not executable weekend quotes.
Source (Nov. 13) · Reuters (Nov. 13)
Applied MaterialsAMAT
Catalyst: Nov. 12 earnings beat: adjusted EPS $4.16; fiscal Q1 revenue outlook around $11.1B, above $10.89B consensus. Management sees strong advanced chipmaking equipment demand.
Valuation: approximately 29.5x trailing earnings, not an obvious bargain despite the earnings beat; assess forward earnings quality and cycle durability.
Upside thesis: equipment spending on advanced AI chips persists into 2027.
Key risks: export restrictions, supply constraints, cyclicality, sector selloff and high expectations.
What to watch: review post-earnings guidance and wait for selling pressure to stabilize before considering a staged entry.
Sources (Nov. 12–13): Reuters; MarketBeat
Cisco SystemsCSCO
Catalyst: fiscal Q1 revenue $18.5B, +24%; raised FY2027 revenue forecast to $74.8–75.8B and hyperscaler AI infrastructure outlook to $9B. Shares fell 6.2% Friday.
Valuation: roughly 25.5x trailing and 17.2x forward earnings; cheaper forward multiple depends on forecast delivery.
Upside thesis: AI networking and optics demand expand.
Key risks: product-order growth slowing, margin compression, memory costs, hyperscaler capex cycles.
What to watch: reassess after earnings-related analyst revisions; avoid assuming a one-day drop automatically creates value.
Sources (Nov. 12–13): Reuters; Investor's Business Daily; StockAnalysis
Brookfield CorporationBN
Catalyst: Q3 distributable earnings about $1.7B, up 16%; fundraising and wealth solutions growth. Analyst revisions followed the report.
Valuation: about 35.6x GAAP trailing EPS, but GAAP P/E is a poor stand-alone measure for this multi-asset business; examine distributable earnings, asset values, debt and fee-bearing capital instead.
Upside thesis: compounding through asset management, insurance/wealth solutions, and real assets.
Key risks: leverage, property/credit valuations, interest rates, complex accounting and asset liquidity.
Research next: build a sum-of-the-parts estimate before any purchase.
Sources (Nov. 12–13): Investing.com; StockAnalysis; Benzinga
FortisFTS.TO
Catalyst: C$32.2B planned capital investment in 2027–2031 and another 4% dividend increase.
Valuation: roughly 21.2x trailing earnings and about 3.1% indicated dividend yield, which limits the margin of safety for a regulated utility.
Upside thesis: rate-base expansion supports long-term earnings and dividends.
Key risks: interest rates, financing needs, regulatory decisions and execution on the capital plan.
Research next: compare with Canadian utility peers and wait for a more attractive yield/valuation if income is the priority.
Sources (Nov. 3–14): TMX Money; StockSummarizer
Franco-NevadaFNV
Catalyst: Q3 results and ongoing precious-metals royalty cash flow.
Valuation: roughly 30.3x trailing and 26.8x forward earnings; this is a quality premium, not a cheap gold proxy.
Upside thesis: gold royalties offer exposure without direct mine-operating costs.
Key risks: gold-price declines, Cobre Panama uncertainty, counterparties and project delivery.
What to watch: use as a potential diversifier only after testing valuation under lower gold prices.
Sources (Nov. 11–13): StockAnalysis; Newswire
Monday research priorities
AMAT and CSCO post-earnings revisions; BN sum-of-parts valuation. FTS and FNV are defensive/diversification candidates, but neither is obviously inexpensive at Friday’s close.
These are general research ideas, not personalized investment advice. Prices are verified Friday Nov. 13 closing prices; verify fresh quotes and filings before trading. No price targets or returns are guaranteed.
This article is for general information only and is not financial, tax, legal or insurance advice. Check the official sources linked in the article and speak with a qualified professional about your own situation.
Comments
Post a Comment